Bluejay Diagnostics, Inc. (BJDX) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $5.16M | +20.1% |
| 2024 | $4.30M | +94.8% |
| 2023 | $2.21M | -78.2% |
| 2022 | $10.11M | -46.9% |
| 2021 | $19.05M | +1987.7% |
| 2020 | $912.4K | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $5.16M | +20.1% |
| 2024 | $4.30M | +94.8% |
| 2023 | $2.21M | -78.2% |
| 2022 | $10.11M | -46.9% |
| 2021 | $19.05M | +1987.7% |
| 2020 | $912.4K | — |